EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hormone Receptor Positive/HER2 Negative Breast Carcinoma: Association of PIK3CA Mutational Status with PD-L1 and Tumor Cell Microenvironment and Their Prognostic Significance

Danijel Lopac iD, Emina Babarović iD, Justin Hagen, Petra Valković Zujić iD, Damir Grebić, Ita Hadžisejdić iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Danijel Lopac und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Orthopedic Surgery, 51415 Lovran, Croatia. Hauptthemen laut MEDLINE: Breast Neoplasms, Class I Phosphatidylinositol 3-Kinases, B7-H1 Antigen, Neoplasm Recurrence, Local. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Rijeka, project of the University of Rijeka.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel research data in different cancer types indicate that mutations within PIK3CA might serve as a biomarker of an improved response to immune therapy. Therefore, the aim of this study was to evaluate and examine possible differences in the tumor microenvironment composition and PD-L1 expression as well the prognostic significance of CD4, CD8, CD68, and CD163 in PIK3CA mutated and non-mutated hormone receptor positive and HER2 negative (HR+/HER2−) breast carcinoma. Breast carcinoma tissue was analyzed by Cobas PIK3CA mutation test for the presence of PIK3CA mutation and immunohistochemistry was applied to assess PD-L1 expression and CD4, CD8, CD68, and CD163 infiltration within tumor. Statistically significant association was observed between PD-L1 expression and the presence of PIK3CA exon 20 mutation (p = 0.044), with PD-L1–positive patients predominantly harboring this mutation. Tumors harboring PIK3CA mutations exhibited moderate to strong statistically significant positive correlations between PD-L1 expression and infiltration by CD8 cells (rs = 0.462, p = 0.0027), CD68 cells (rs = 0.398, p = 0.0134), and CD163 cells (rs = 0.617, p < 0.0001). In patients with PIK3CA mutation and exon 20 PIK3CA mutation there was statistically significant longer survival without recurrence (p = 0.026 and p = 0.041, respectively). Research regarding PD-L1 expression, immune cells and PIK3CA mutations might have an impact on how to determine therapeutic approaches for patients with HR+/HER2− breast carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsClass I Phosphatidylinositol 3-KinasesB7-H1 AntigenNeoplasm Recurrence, LocalBiomarkers, TumorPrognosisTumor MicroenvironmentErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneGene Expression Regulation, NeoplasticExonsBreastLymphocytes, Tumor-InfiltratingRetrospective StudiesKaplan-Meier EstimateHumansFemaleMiddle AgedCarcinomaDNA Mutational Analysis

Stichwörter der Autor:innen

PD-L1PIK3CA mutationbreast cancerimmune infiltrate

Substanzen

PIK3CA protein, humanClass I Phosphatidylinositol 3-KinasesBiomarkers, TumorERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneCD274 protein, humanB7-H1 Antigen

Autor:innen und Institutionen

  • Clinic for Orthopedic Surgery, 51415 Lovran, Croatia.
  • Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
  • Clinical Department of Pathology and Cytology, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia.
  • Clinical Department of Diagnostic and Intervetional Radiology, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia.
  • Department of Surgery, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia.

ORCID-Profile: Danijel Lopac, Emina Babarović, Petra Valković Zujić, Ita Hadžisejdić

Förderung

  • University of Rijeka
  • project of the University of Rijeka

Zitieren

APA

Lopac, D., Babarović, E., Hagen, J., Valković Zujić, P., Grebić, D., & Hadžisejdić, I. (2025). Hormone Receptor Positive/HER2 Negative Breast Carcinoma: Association of PIK3CA Mutational Status with PD-L1 and Tumor Cell Microenvironment and Their Prognostic Significance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199489

Vancouver

Lopac D, Babarović E, Hagen J, Valković Zujić P, Grebić D, Hadžisejdić I. Hormone Receptor Positive/HER2 Negative Breast Carcinoma: Association of PIK3CA Mutational Status with PD-L1 and Tumor Cell Microenvironment and Their Prognostic Significance. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199489

BibTeX
@article{Lopac2025,
  author = {Lopac, Danijel and Babarović, Emina and Hagen, Justin and Valković Zujić, Petra and Grebić, Damir and Hadžisejdić, Ita},
  title = {Hormone Receptor Positive/HER2 Negative Breast Carcinoma: Association of PIK3CA Mutational Status with PD-L1 and Tumor Cell Microenvironment and Their Prognostic Significance},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199489}
}
Kostenlos starten →